Cheap, Unloved, Profitable: The Case for Value Investing Today

Temple Bar’s Ian Lance says the trust’s standout performance since 2020 has been driven by disciplined value investing: buying unloved, low-priced companies with recovery potential and holding them as sentiment improves. The article frames the strategy as a focus on long-term earnings rather than short-term pessimism, even when it requires owning controversial stocks. The piece is commentary-heavy and is unlikely to move markets broadly, but it reinforces a constructive case for value-oriented positioning.

Analysis

The signal here is less about one trust’s outperformance and more about a regime where cheapness is finally being monetized. In markets dominated by passive flows and momentum, disciplined value can work when dispersion is high and balance-sheet repair is underway; the second-order effect is that the cheapest names often become self-help stories as management teams are forced into buybacks, asset sales, and cost cuts. That creates a reflexive loop: improving sentiment lowers the cost of capital, which can matter more than near-term earnings revisions.

The main beneficiary set is not just the obvious “unloved” cyclicals, but also suppliers and adjacent businesses that gain from any restart in capex and operating leverage. The underappreciated loser is the crowded quality-growth basket that has been priced for perfection; if value keeps working, the relative performance gap can widen quickly because many institutions are underweight deep value and overexposed to long-duration names. That makes this theme less about absolute returns and more about positioning squeeze.

The risk is that value traps stay trapped longer than investors can tolerate. If the economy weakens into the next 1-2 quarters, low-multiple businesses with weak end markets will look cheap for good reason, and the strategy’s winners will need real earnings inflection rather than just multiple expansion. The catalyst to watch is whether corporate results confirm that pessimism was overdone; absent that, the market can rotate back to quality growth very quickly.

Consensus is probably underestimating how much of recent value outperformance has been driven by valuation compression unwinding rather than durable fundamental re-rating. That means the trade is not to buy every cheap stock, but to target names where sentiment is depressed while earnings power is relatively intact and capital allocation can accelerate the re-rate. In other words, the edge is in distinguishing cyclical recovery from structural decline.

Key Decisions for Investors

• Go long a basket of high-quality UK/European value names with net cash and visible buyback capacity for a 3-6 month trade; target 15-20% upside if the re-rating persists, with 8-10% downside if macro weakens.
• Pair trade: long deep-value financials/industrial turnarounds vs short high-multiple defensives/growth where positioning is crowded; expect 5-8% relative outperformance over 1-2 quarters if dispersion stays elevated.
• Buy call spreads on a broad value ETF or regional bank ETF into any pullback over the next 2-4 weeks; use defined-risk structures because the main failure mode is a sudden reversal to quality.
• Avoid indiscriminate exposure to the cheapest balance-sheet-stressed names; focus on companies with 12-month catalysts such as asset sales, margin normalization, or buyback acceleration, because time is the enemy of pure valuation trades.